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Background: The link between dietary fat and coronary heart disease has attracted much 
attention since the effect of long-chain fatty acids on gene transcription has been established.  The 
aim of this study was to investigate the effects of long-chain fatty acids and clofibrate on mRNA 
levels of specific lipid metabolism-related genes and to determine their effects on global 
transcriptome levels in a cardiovascular cell-line. 
Methods: After culturing P19CL6 cells with long-chain fatty acids or clofibrate, the expression 
levels of heart-type fatty-acid binding protein and peroxisome proliferators-activated receptors 
(PPARα,β,γ) were determined by reverse transcriptase-polymerase chain reaction.  Additionally, 
global transcriptome profiles were compared using microarray analysis.   
Results: Long-chain fatty acids significantly increased the abundance of PPARα and PPARγ.  
Moreover, microarray analysis showed that the effects of linoleic and α-linolenic acids, and 
clofibrate were similar but differed from those of palmitic and oleic acids. 
Conclusion: These findings show that cellular responses to polyunsaturated fatty acids differ 
from those observed with saturated and monounsaturated fatty acids.  
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Introduction 
 
oronary heart disease (CHD) is the 
leading cause of death in developed 
countries1, 2 and its prevention and 
treatment continues to be a significant challenge.3  
The link between dietary fat and heart disease has 
been clearly established.4,5 Saturated fatty acids 
(SFAs) are considered as atherogenic fat, whereas 
polyunsaturated fatty acids (PUFAs) are 
cardioprotective.5–8 Many of the potentially 
beneficial effects of dietary PUFAs  in preventing 
or inhibiting the progression of CHD are mediated 
through the control of gene transcription.5,9 The 
regulatory    function   of   long-chain   fatty   acids  
 
 
(LCFAs) on gene expression is achieved by 
controlling the abundance and activity of 
transcription factors such as sterol regulatory 
element-binding protein, liver X-receptor, and 
peroxisome proliferators-activated receptors 
(PPARα,β,γ).10–13    
Several cell culture and animal model systems 
have been used to study the effects of LCFAs and 
fibrates at the gene expression level.8,14–18  
However, there are a limited suitable 
cardiovascular model systems available for the in 
vitro investigation of FA effects on cardio-
myocytes.19,20 The P19Cl6 cell-line used in this 
study is a subclone of P19 mouse embryonal 
carcinoma cells that has been reported to 
efficiently differentiate into cardiomyocytes upon 
exposure to dimethyl sulfoxide (DMSO).21  
Therefore, based on the effects of LCFAs and 
fibrates on the other cardiomyocyte model 
systems, it was hypothesized that the mRNA levels 
of lipid metabolism-related genes such as heart-
type fatty acid-binding protein (H-FABP), PPARα, 
PPARβ, and PPARγ would be affected by these 
ligands in P19CL6 cells.  In addition, since the 
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effects of FAs differ based on their chain length 
and degree of unsaturation,22,23 it was hypothesized 
that LCFAs would differentially affect the 
expression levels of these proteins.  Furthermore, 
the effects of LCFAs and fibrates on global 
transcriptome levels were investigated in order to 
obtain a broader picture of the effects of these 
compounds on gene expression levels in the 
P19CL6 cell-line.  Therefore, the aim of this study 
was to investigate the effects of LCFAs including 
palmitic (saturated FA), oleic (monounsaturated 
FA), linoleic (n-6 polyunsaturated FA), and 
α-linolenic (n-3 polyunsaturated FA) acids, as well 
as clofibrate on gene expression levels in  
P19CL6 cells. 
 
Materials and Methods 
 
Sigma-Aldrich Company Ltd. (Poole, UK) 
supplied 100× penicillin-streptomycin and DMSO. 
Fetal bovine serum (FBS), α-minimum essential 
medium (α-MEM), Trizol reagent, and 
phosphate-buffered saline (PBS) tablets were 
obtained from Invitrogen Corporation (Paisley, 
UK). Nested polymerase chain reaction (PCR) kit 
and agarose for gel electrophoresis were purchased 
from Promega Corporation (Southampton, UK) 
and MWG Biotech Ltd. (Milton Keynes, UK) 
supplied oligonucleotide primers.  Ready-To-Go 
reverse transcriptase-PCR  (RT-PCR) kit, 
Microarray Slides, Cy3-dCTP (labeled 2'-
deoxycytidine 5'-triphosphates ), and Cy5-dCTP 
fluorescent dyes were obtained from Amersham 
Biosciences (Chalfont St. Giles, UK). Corning Life 
Sciences (Corning B.V. Life Sciences, 
Schiphol-Rijk, Netherlands) supplied ProntoPlus 
microarray kit.  RNeasy® MinElute™ Cleanup kit, 
RNase-free DNase, and MinElute PCR 
purification kit were obtained from Qiagen Ltd. 
(Crawley, UK).  Tissue culture plates were 
provided by Nunclon Products (Nunclon, Roskilde, 
Denmark) and 150 cm2 peel-off flasks were 
obtained from Helena BioSciences Europe Ltd. 
(Sunderland, UK).  
 
Methods  
Cell culture 
P19CL6 cells were purchased from Riken Cell 
Bank (Ibaraki, Japan),21 and cultured in normal 
culture media containing α-MEM supplemented 
with 10% FBS and 1% penicillin-streptomycin.  To 
differentiate P19CL6 cells into cardiomyocytes, 
P19CL6 cells were cultured in 150 cm2 peel-off 
flasks at a density of 2×106 cells per flask using 
30 mL of a DMSO-containing medium 
(α-MEM/10% FBS/1% DMSO/1%penicillin-
streptomycin) for 14 days.  At the end of the day 
14, medium was removed and cells were washed 
twice with 15 mL PBS and incubated in 25 mL of 
a serum-free medium (98%α-MEM/1% penicillin-  
streptomycin/ 1% DMSO) for 24 hours (day 15).  
The cells were then treated with media either 
containing bovine serum albumin (BSA), as carrier 
(98% α-MEM/ 1% penicillin-streptomycin/ 
1% DMSO/ 0.15 mM BSA), BSA-FA complex 
(98% α-MEM/ 1% penicillin-streptomycin 
1% DMSO/0.15 mM BSA with 0.4 mM FA), or 
BSA-clofibrate complex (98% α-
MEM/1%penicillin-streptomycin/ 1%  DMSO/0.15 
mM BSA with 0.4 mM clofibrate) for 24 hours.21,24  
Finally, the  medium was aspirated off and cells 
were washed with 15 mL PBS.  Cell lysate was 
obtained by adding 15 mL of Trizol reagent (1 mL 
per 10 cm2 culture area) and stored at –80°C until 
RNA extraction.   
 
Preparation of BSA/FA complex 
An appropriate amount of BSA was dissolved 
in a serum-free medium to obtain a concentration 
of 0.15 mM BSA.  In the next step, FA or 
clofibrate powder was dissolved in 100 mM NaOH 
to prepare a 100 mM stock solution24; the latter 
was then diluted at the ratio of 1:250 with 
serum-free medium containing 0.15 mM BSA to 
achieve a final concentration of 0.4 mM (or 
clofibrate).   
 
Total-RNA isolation and purification  
Total RNA was isolated by the direct addition 
of Trizol reagent to the cells (1 mL per 10 cm2 of 
cell culture area) and proceeding manufacturer’s 
instructions. For microarray experiments the 
total-RNA samples were treated with DNase-I 
enzyme to remove potential genomic DNA 
contamination and purified using RNeasy 
MinElute Spin columns.  Finally, a NanoDrop 
ND-1000 spectrophotometer (NanoDrop 
Technologies, Montchanin, USA) was used to 
determine total-RNA concentration. The ratio of 
absorbance at 260 and 280 nm (A260/A280) was 
used to assess purity of RNA samples with a ratio 
of 1.8 – 2.0 generally being accepted as pure 
RNA.25,26 
 
Determination of mRNA levels  
To determine gene expression levels, the  levels 
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of specific mRNAs were determined by RT-PCR 
using relevant gene-specific forward and reverse 
primers.  In some experiments, RT-PCR products 
were reamplified by nested PCR to achieve higher 
cDNA levels.27,28 Primers for both RT-PCR and 
nested PCR techniques were designed using 
Primer-3 software (Primer3™, Whitehead Institute 
for Biomedical Research, Cambridge, UK). In 
order to get semiquantitative values of gene 
expression levels, agarose gels (2%) containing 
ethidium bromide were used.  PCR products were 
then separated by electrophoresis at 100 V and the 
gels photographed using an ImageMaster VDS 
UV-light camera (Amersham Pharmacia Biotech, 
San Francisco, USA). The photographic images of 
gels were then digitized using the Scion Image 
program (ScionImage™, Scion Corporation, 
Maryland, USA) and gene expression levels were 
determined relative to the expression of 
housekeeping gene glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH).29   
 
Microarray experiments  
Microarray experiment was designed as 
dual-hybridization optimal interwoven loop 
(Figure 1) using an online microarray experimental 
design program, MARIE software (MARIE™, 
Biotechnology and Biological Sciences Research 
Council, Swindon, UK).30–32   
Microarray experiment was carried out in a 
step-by-step procedure including cDNA synthesis 
and labelling by fluorescent dye,25 purification of 
labeled-cDNA, and hybridization of labeled-cDNA 
on arrays, as indicated in ProntoPlus kit 
instructions.  Images were acquired by scanning of 
arrays using an Affymetrix 428 scanner 
(Affymetrix, Santa Clara, USA).  BlueFuse 
software (BlueGenome Ltd., Great Shelford, UK) 
was used for image analysis and the microarray 
data further analysed using Gene Spring-7 software 
(Silicon Genetics, Redwood City, USA). After 
normalization and filtering of microarray data, 
linear modeling (LLAMA; Live Linear Analysis of 
MicroArray) was performed (LLAMA™, 
Biotechnology and Biological Sciences Research 
Council, Swindon, UK) in order to convert the data 
from the loop experiment into a linear model.33-35 
The data produced by linear modeling were 
imported into a web-based clustering program 
(Cluster™, Lawrence Brekely  National  
Laboratory, Brekely,  USA)36 to generate a pair- 
wise linkage cluster.   Analysis  formed a hierarch- 
 
Figure 1. Experimental loop design to compare global transcriptome levels in P19CL6 cells cultured with LCFAs or 
clofibrate.  (A) Loop design showing the six samples (nodes) to be compared.  The sample at the start of the arrow 
was labeled with Cy3 and the “target” sample with Cy5.  (B) Samples and Cy-dye labeling used on different microarray 
slides, based on the loop design.  S1-S6=slide numbers.  ALA=α-linolenic acid; BSA=bovine serum albumin; Clo= 
clofibrate; LA=linoleic acid; OA=oleic acid; PA=palmitic acid. 
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 ical cluster based on the phylogenetic algorithm, 
which was then visualized with TreeView software 
(TreeView™, Lawrence Brekely National 
Laboratory, Brekely, USA ).36    
 
Results 
 
In order to determine the effects of LCFAs and 
fibrates on gene expression levels, P19CL6 cells 
were cultured with 0.4 mM LCFAs or clofibrate, as 
discussed in the Materials and Methods. The 
mRNA expression of H-FABP, PPARα, PPARβ, 
and PPARγ in P19CL6 cells was detected by 
RT-PCR followed by nested PCR techniques.  
Semiquantitative gene expression levels, relative to 
GAPDH expression, were then calculated 
(Table 1). A One-way ANOVA analysis was 
conducted to explore the impact of LCFAs or 
clofibrate on gene expression. The expression of 
H-FABP and PPARβ did not display significant 
changes with LCFAs or clofibrate (Table 1).  
However, LCFAs had a significant effect (P<0.05) 
on the expression of PPARα and PPARγ in 
P19CL6 cells (Table 1).  In addition, levels of 
PPARα and PPARγ mRNA were significantly 
increased with all the LCFAs, but not with  
clofibrate (Table 1). Although this semi-
quantitative data may be indicative of the 
underlying biologic response, it should be viewed 
as preliminary, and therefore, in order to get a 
wider prospective on the effects of LCFAs and 
clofibrate in P19CL6 cells, microarray analysis 
was used to investigate global transcriptome 
profiles in the cells cultured with these ligands. 
The data from microarray experiment were 
converted into a linear model, which was 
subsequently imported into Gene Cluster program.  
Complete-linkage hierarchical cluster analysis of 
microarray data showed that expression levels in 
cells treated with linoleic acid (LA) or α-linolenic 
acid (ALA) were similar and closely related to the 
general effect observed with clofibrate-treated cells 
(Figure 2). A similar pattern was also shown with 
principal component analysis (PCA) confirming 
that LA, ALA, and clofibrate were closely related 
to each other (Figure 3) but differed from that of 
palmitic acid (PA) and oleic acid (OA) (Figures 2 
and 3).  
 
Discussion  
 
The study of mammalian gene expression is 
often carried out at the level of mRNA and relies 
upon techniques for identification and quantitation 
of mRNA species coding for specific proteins.  
Several methods have been developed for this 
purpose, each offering distinct advantages and 
disadvantages.37 The most common techniques to 
measure gene expression involve Northern 
hybridization analysis, ribonuclease protection, and 
RT-PCR.37,38 The latter has become the benchmark 
for detection and quantification of RNA targets 
and is utilized increasingly in clinical diagnostic 
assays.38,39 However, despite the advantages and 
the greater accuracy of real-time RT-PCR in 
quantification of a distinct gene or a 
disease-specific diagnostic marker,38 semi-
quantitative RT-PCR methods are still widely used 
for many purposes.40  
Here, in order to determine the effect of LCFAs 
and clofibrate on gene expression levels in 
P19CL6 cells, the mRNA expression levels of lipid 
metabolism-related genes, i.e., H-FABP, PPARα, 
PPARβ, and PPARγ were initially investigated by 
semiquantitative PCR analysis in a focused study, 
while global transcriptome levels were 
subsequently studied by microarray analysis.   
A semiquantitative estimation of gene 
expression levels, using RT-PCR, in P19CL6 cells 
cultured with LCFAs or clofibrate (0.4 mM) 
showed   no  significant  difference  in  the  relative 
expression levels  of H-FABP  (Table 1).  Previous 
Table 1. Comparison of relative H-FABP, PPARα, PPARβ, and PPARγ gene expression levels in P19CL6 cells 
cultured with different LCFAs or clofibrate. 
Gene expression relative to GAPDH (mean±SD) 
Gene 
BSA PA OA LA ALA Clo 
H-FABP 1.22±0.11 1.15±0.18 1.27±0.12 1.22±0.27 1.27±0.23 1.23±0.16 
PPARα 1.27±0.14 1.70±0.40a 1.89±0.19b 1.99±0.16b 2.04±0.24b 1.49±0.15 
PPARβ 0.97±0.37 1.09±0.16 1.16±0.23 1.37±0.33 1.35±0.17 1.11±0.17 
PPARγ 1.21±0.23 1.78±0.21a 1.96±0.22b 2.14±0.26b 1.80±0.26a 1.24±0.20 
Data are shown as mean±standard deviation and significant differences in gene expression levels relative to BSA treatment were indicated as 
aP<0.05, and bP<0.001. ALA=α-linolenic acid; BSA=bovine serum albumin; Clo=clofibrate; LA=linoleic acid; OA=oleic acid; PA=palmitic acid.   
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studies have shown that LCFAs or fibrates 
up-regulate H-FABP in cardiomyocytes.41-43  
However, other studies have shown no changes in 
H-FABP mRNA after a high-fat diet.42,44  Similar 
contradictory observations have also been reported 
on the expression of H-FABP in skeletal muscle 
cells, indicating no significant response in cellular 
H-FABP content to high-fat diet for one week,44,45 
whereas long-term (four weeks) supplementation 
significantly increased expression of H-FABP 
mRNA.45  Therefore, the nonresponse of H-FABP 
expression levels, as observed in our study, can 
probably be explained by the relatively short 
exposure time (24 hours). This leads to the 
conclusion that H-FABP gene expression responds 
slowly to LCFAs and clofibrate, and incubations 
for longer than 24 hours would probably be 
required before any effects of these ligands on 
H-FABP mRNA expression would be observed. 
P19CL6 cells cultured with LCFAs or 
clofibrate also showed no significant changes in 
the relative expression level of PPARβ, whereas 
the expression of PPARα and PPARγ was 
significantly increased in the presence of LCFAs, 
regardless of the chain length and degree of 
unsaturation (Table 1).  Therefore, the observations 
made in this study are in agreement with previous 
studies, which showed that dietary fat and fibrates 
increased PPARα and PPARγ expression levels in  
different tissues.46-49 Unlike the significant increase  
observed in PPARα and PPARγ expression levels, 
incubation  of   P19CL6    cells   with   LCFAs   or  
clofibrate did not affect the expression of PPARβ 
(Table 1). This observation is consistent with 
previous reports that showed the ingestion of 
dietary fat had no effect on PPARβ expression 
levels, as shown in rat colonic mucosa and human 
endothelial cells.50,51   
In this study, P19CL6 cells cultured with 
clofibrate showed no statistically significant 
change in the expression levels of the PPAR 
isoforms (Table 1), although, the induction of 
PPARα mRNA by clofibrate has been shown in 
other model systems.52–54 The nonresponse of 
PPARα gene expression level observed here can 
probably be explained by the short exposure time 
(24 hours),55 because long-term incubations have 
been mainly used in other studies.52,54   
In addition to the effect of LCFAs and 
clofibrate on H-FABP, PPARα, PPARβ, and 
PPARγ expression level, the effects of these 
ligands on global transcriptome levels in the 
P19CL6 cell-line were also investigated by cDNA 
microarray analysis.  LA, ALA, and clofibrate 
showed similar effects, as shown by cluster 
analysis (Figure 2) and PCA (Figure 3), whereas 
PA and OA had a different effect (Figures 2 
and 3).  These observations are in agreement with 
previous studies that showed dietary SFAs and 
PUFAs had different effects on gene expression.56-
59  This could be explained by differences in the 
affinity of SFA and PUFA to activate nuclear 
receptors.11,60,61  The effect of clofibrate on global 
transcriptome profiles was also more closely 
related to LA and ALA than PA or OA (Figures 2 
and 3). Therefore, the effect of PUFAs were 
similar to that of clofibrate, but differed from that 
of SFA which is a  monounsaturated fatty acid.   
In conclusion, both RT-PCR and microarray 
experiments showed that culturing  P19CL6  cells  
 
Figure 2. Hierarchical cluster analysis of mRNA expression levels in microarrays comparing the P19CL6 cells cultured 
with LCFAs and clofibrate. The comparisons were clustered according to the degree of pair-wise similarity. The color 
gradient represents green for down-regulation and red for up-regulation.  Each gene is represented by a single row 
and comparisons are demonstrated by columns.  ALA=α-linolenic acid; BSA=bovine serum albumin; Clo=clofibrate; 
LA= linoleic acid; OA=oleic acid; PA=palmitic acid. 
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with LCFAs or clofibrate affected gene expression.  
PCR experiments confirmed that LCFAs affect the 
abundance of PPARα and PPARγ, but not PPARβ 
or H-FABP under the conditions used.  Microarray 
experiments, on the other hand, showed that the 
effects of LA, ALA, and clofibrate were similar 
but differed from those of PA and OA.  In addition, 
the effect of clofibrate was similar to those of 
PUFAs. 
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